Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

OSTARA BIOMEDICAL LIMITED

Company number 08322823

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 Oct 2019 PSC08 Notification of a person with significant control statement
10 Oct 2019 PSC07 Cessation of The North West Fund for Biomedical Lp as a person with significant control on 4 October 2019
11 Jan 2019 CS01 Confirmation statement made on 7 December 2018 with updates
21 Nov 2018 SH01 Statement of capital following an allotment of shares on 2 November 2018
  • GBP 643
01 Nov 2018 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
31 Oct 2018 SH08 Change of share class name or designation
31 Oct 2018 SH08 Change of share class name or designation
26 Oct 2018 SH01 Statement of capital following an allotment of shares on 23 October 2018
  • GBP 594.78
15 Jun 2018 AA Total exemption full accounts made up to 31 March 2018
11 Apr 2018 AP01 Appointment of Dr Andrew Edward Round as a director on 11 April 2018
20 Dec 2017 CS01 Confirmation statement made on 7 December 2017 with no updates
25 Oct 2017 AA Total exemption full accounts made up to 31 March 2017
27 Jun 2017 TM01 Termination of appointment of Edwina Mary Wright as a director on 1 June 2017
30 Dec 2016 AA Total exemption full accounts made up to 31 March 2016
22 Dec 2016 CS01 Confirmation statement made on 7 December 2016 with updates
13 Sep 2016 TM01 Termination of appointment of Nwf4B Directors Limited as a director on 13 September 2016
13 Sep 2016 CH01 Director's details changed for Ms Nadia Orsi on 12 September 2016
04 Apr 2016 SH01 Statement of capital following an allotment of shares on 7 March 2016
  • GBP 6,798.00
04 Apr 2016 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities
27 Jan 2016 SH01 Statement of capital following an allotment of shares on 27 November 2015
  • GBP 223.00
27 Jan 2016 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
04 Jan 2016 AR01 Annual return made up to 7 December 2015 with full list of shareholders
Statement of capital on 2016-01-04
  • GBP 358.71
20 Nov 2015 AP01 Appointment of Dr David Laurence George Danson as a director on 20 November 2015
20 Nov 2015 TM01 Termination of appointment of Michael John Norris as a director on 20 November 2015
04 Oct 2015 AA Total exemption full accounts made up to 31 March 2015